TRT and Fertility in NYC: Protecting Sperm Production, hCG Protocols, and How to Come Off Testosterone Safely

Testosterone replacement therapy solves one problem and quietly creates another. Men who start TRT in NYC often feel dramatically better within weeks — more energy, better mood, restored libido, easier training recovery. What many are never told at the start is that exogenous testosterone suppresses the body's own testosterone production and, in most men, sharply reduces sperm production. For a 52-year-old who is finished having children, that trade-off may be acceptable. For a 34-year-old who plans to start a family in three years, it is a decision that deserves a conversation before the first injection, not after.

At Regen Health Physicians, Dr. Ajit Dhaliwal treats hormone optimization as a fertility-aware discipline. This article explains the physiology of TRT-induced suppression, which protocols preserve fertility, how to restart natural production if you want to come off testosterone, and what realistic timelines look like.

Why TRT Shuts Down Your Own Testosterone

Testosterone production is governed by a feedback loop called the hypothalamic-pituitary-gonadal (HPG) axis. The hypothalamus releases gonadotropin-releasing hormone (GnRH) in pulses. GnRH tells the pituitary to release two hormones: luteinizing hormone (LH), which stimulates the Leydig cells in the testes to produce testosterone, and follicle-stimulating hormone (FSH), which — together with very high intratesticular testosterone concentrations — drives sperm production in the Sertoli cells.

The loop is self-regulating. When circulating testosterone and estradiol rise, the hypothalamus and pituitary reduce GnRH, LH, and FSH output. That is exactly what happens on TRT: the brain detects abundant testosterone in the blood and stops signaling the testes. LH and FSH fall toward zero, the testes become quiescent, and testicular volume often decreases over months.

The critical point that surprises most patients is this: blood testosterone and intratesticular testosterone are not the same thing. Sperm production requires testosterone concentrations inside the testis roughly 50 to 100 times higher than blood levels. No dose of injected, topical, or pelleted testosterone reproduces that gradient — it can only be generated locally, by LH-stimulated Leydig cells. So a man on TRT can have an excellent serum testosterone level of 800 ng/dL and still have severely impaired or absent sperm production. Studies of testosterone as a male contraceptive found azoospermia (no measurable sperm) in the large majority of participants within a few months of starting.

Who Needs to Think About This

Fertility preservation should be part of the initial consultation for any man who:

• Is under roughly 45 and has not completed his family
• Is uncertain about future children, including in a future relationship
• Has a partner planning pregnancy within the next several years
• Already has known fertility risk factors — varicocele, prior chemotherapy, undescended testis history, or a low baseline sperm count
• Wants the option of coming off therapy later without a prolonged recovery period

If none of those apply — the man is older, his family is complete, and he understands the change is likely long-term — standard TRT is a reasonable choice. The mistake is not choosing TRT. The mistake is choosing it without knowing what it does.

Baseline Testing Before You Start

Comprehensive hormone optimization begins with data, not a prescription. Before any man starts therapy at RHPNY, we establish:

Two morning total testosterone levels, drawn before 10 a.m. on separate days. A single low reading is not a diagnosis; testosterone is pulsatile and diurnal, and stress, illness, or poor sleep can transiently depress it.

Free testosterone and SHBG. Sex hormone-binding globulin determines how much testosterone is biologically available. Men with high SHBG can have a "normal" total level and genuinely low free testosterone.

LH and FSH. These distinguish primary hypogonadism (testicular failure — LH and FSH high) from secondary hypogonadism (pituitary/hypothalamic signaling problem — LH and FSH low or inappropriately normal). This distinction matters enormously for fertility, because secondary hypogonadism often responds to therapies that raise your own testosterone rather than replacing it.

Estradiol (sensitive assay), prolactin, and a metabolic panel. Elevated prolactin can signal a pituitary adenoma and requires imaging. Prolactin, thyroid dysfunction, insulin resistance, obstructive sleep apnea, and chronic opioid use are all reversible contributors to low testosterone that deserve treatment in their own right.

A baseline semen analysis for any man who may want children. This is the single most useful and most frequently skipped test. If a man's count is already marginal before therapy, that changes the risk calculation completely — and if he later has trouble conceiving, a baseline tells you whether TRT was the cause.

CBC and PSA. TRT raises hematocrit and requires monitoring; men over 40 need a prostate baseline.

Fertility-Sparing Alternatives to Standard TRT

For men with secondary hypogonadism, several options raise testosterone while keeping the HPG axis running.

Enclomiphene and Clomiphene

Clomiphene citrate is a selective estrogen receptor modulator that blocks estrogen feedback at the hypothalamus. The brain interprets this as low estrogen, increases GnRH output, and LH and FSH rise — stimulating the testes to make their own testosterone. Enclomiphene is the purified trans-isomer, which carries most of the LH-raising effect with fewer of the mood and visual side effects attributed to the zuclomiphene isomer.

Published series consistently show clomiphene roughly doubling serum testosterone in men with secondary hypogonadism while maintaining or improving sperm parameters. Use in men is off-label in the United States, and both patients and prescribers should understand that. It works best in men whose testes are capable of responding — that is, men whose LH is low or low-normal, not men with primary testicular failure.

hCG Monotherapy

Human chorionic gonadotropin is structurally similar to LH and binds the same receptor. It stimulates Leydig cells directly, raising both serum and — critically — intratesticular testosterone. Some men achieve adequate symptom relief on hCG alone, typically dosed subcutaneously two to three times weekly, preserving testicular volume and spermatogenesis.

hCG Added to TRT

For men who need the reliability of testosterone but want to protect fertility, adding low-dose hCG alongside TRT is a well-established strategy. Because hCG maintains Leydig cell stimulation, intratesticular testosterone is preserved even while the pituitary is suppressed. Research from academic andrology groups has shown that men on testosterone plus low-dose hCG maintained sperm production over extended follow-up, whereas testosterone alone typically did not. This does not guarantee fertility, but it substantially improves the odds and shortens recovery if therapy is stopped.

Sperm Cryopreservation

The most reliable insurance policy is the least glamorous one: bank sperm before starting. Cryopreservation is inexpensive relative to fertility treatment, widely available in New York City, and removes the uncertainty entirely. We recommend it for any man under 45 who is not certain his family is complete.

Coming Off TRT: The Restart Protocol

Men stop testosterone for many reasons — a pregnancy plan, hematocrit that keeps climbing, side effects, cost, or simply a desire to see where their own physiology sits. A structured restart is far more comfortable and more successful than abruptly quitting.

Phase 1 — hCG priming (roughly 3 to 6 weeks). After months or years of suppression, Leydig cells are dormant. Starting hCG while tapering testosterone reawakens them before the pituitary signal is asked to take over. Skipping this step is the most common reason a restart stalls with a hard crash in symptoms.

Phase 2 — SERM phase (roughly 6 to 12 weeks). Clomiphene or enclomiphene restores pituitary LH and FSH output. In some protocols an aromatase inhibitor is added briefly if estradiol rises disproportionately, though this should be guided by sensitive-assay lab values, not by symptoms alone — over-suppressing estradiol causes joint pain, low libido, and impaired bone density.

Phase 3 — monitored washout. LH, FSH, and total and free testosterone are checked every 4 to 6 weeks. A semen analysis at roughly 3 months and again at 6 months tracks recovery, because spermatogenesis takes about 72 to 90 days per full cycle.

Expected timelines. Pooled analyses of testosterone contraceptive trials found that most men recover sperm concentrations to the fertile range within 6 to 12 months of stopping, with the majority recovering by 12 months and a smaller group taking up to 24 months. Recovery is generally slower with longer duration of use, higher doses, older age, and lower baseline function. Men who used hCG alongside TRT, or who were on therapy for a short period, tend to recover faster.

There is also an honest caveat: a minority of men do not fully return to baseline. This is uncommon, but it is real, and it is the reason baseline testing and cryopreservation matter.

What About Anabolic Steroid Use?

Supraphysiologic anabolic steroid cycles — often multiple compounds at many times replacement dose, sometimes including 19-nortestosterone derivatives — suppress the axis far more profoundly than medical TRT and are associated with longer, less predictable recovery. Men in this situation deserve a non-judgmental clinical evaluation rather than internet protocols. The same principles apply, but timelines are longer and specialist reproductive urology involvement is often warranted.

The Broader Picture: Fertility as a Health Signal

Sperm quality is not an isolated reproductive metric; it correlates with general health. Insulin resistance, visceral adiposity, untreated sleep apnea, chronic inflammation, heavy alcohol use, and environmental heat exposure all degrade both testosterone and semen parameters. Many men referred for hormone therapy improve substantially with a systematic workup of these drivers — which is why RHPNY approaches low testosterone through the same lens as our chronic disease program: find and treat the upstream cause before layering a replacement hormone on top of it.

Where symptoms are driven by recovery, inflammation, or metabolic dysfunction rather than by hormone deficiency alone, targeted peptide therapy and structured lifestyle intervention may address the root problem. And for men whose primary complaint is joint pain or training-related injury that they attribute to "low T," a regenerative orthopedic evaluation — see our regenerative medicine for joint, back and shoulder pain and joint and orthopedic programs — is often the more direct answer.

Frequently Asked Questions

Will my fertility definitely come back if I stop TRT? In most men, yes — typically within 6 to 12 months. It is not guaranteed, and recovery is less predictable after long duration, high doses, or with pre-existing testicular impairment.

Can I father a child while on TRT? It is possible but unlikely if you are on testosterone alone, since most men become azoospermic or severely oligospermic. Do not use TRT as contraception, and do not assume it protects fertility either.

Does hCG hurt my TRT results? No. Most men report preserved testicular size, and some report improved wellbeing, likely because hCG also supports production of other testicular steroids beyond testosterone.

Is enclomiphene better than TRT? It is different, not universally better. It works only if your pituitary and testes can respond, and the testosterone rise is usually more modest than with injectable TRT. For a younger man with secondary hypogonadism and fertility plans, it is often the better first choice.

How often will I need labs? At RHPNY, typically at 6 to 8 weeks after any protocol change, then every 3 to 6 months on a stable regimen — including hematocrit, estradiol, and PSA where appropriate.

Working With RHPNY

Dr. Ajit Dhaliwal sees patients in New York City and Salt Lake City. A hormone consultation includes a full symptom history, comprehensive baseline labs, an explicit conversation about family planning, and a written protocol with monitoring intervals. Where fertility preservation or restart is the goal, we coordinate with reproductive urology as needed.

If you are considering testosterone therapy, are already on it and thinking about children, or want to come off it safely, book a consultation and we will build the plan around your timeline — not just your lab values. You can also read more across our blog or learn about the practice on our about page.

---

Medical disclaimer: This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Testosterone therapy, hCG, clomiphene, enclomiphene, and aromatase inhibitors carry risks and require physician supervision; several of these uses are off-label in the United States. Do not start, change, or stop any medication without consulting a qualified physician. Individual results vary.